arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Penumbra Inc

PEN
$324.57 ▼ -0.26 (-0.08%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
51 Visible periods
29 Metrics
Peer-ranked Benchmarks
Price Chart
70
Health
Good
Neutral
auto_awesome

Analytical Summary

Penumbra Inc shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $12.8B
Dividend Yield
Revenue Growth 14.9%
Op. Margin 10.5%
ROIC 2.0%
FCF / Share $0.83
Trailing P/E 368.8x
Price / Book 8.3x
FCF Yield 0.3%
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

51-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$390.05M
↑ +14.9%
Net Income Profit after all expenses
$32.58M
↓ -16.9%
Operating Margin Operating profit as % of sales
10.5%
↑ +3.1% 64th
FCF / Share Free cash flow per share
$0.83
↓ -55.7%

Health Breakdown

Profitability
67
Returns
75
Cash Quality
65

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 14 years · 51 quarters